Belgian Pharma Stock News

The European market has recently faced challenges, with the pan-European STOXX Europe 600 Index declining by 3.79% amid heightened geopolitical tensions and soaring energy costs, prompting caution from the European Central Bank regarding inflation risks. In this environment of uncertainty, high-growth tech stocks in Europe are gaining attention for their potential to offer resilience and innovation-driven growth, making them an intriguing focus for investors seeking opportunities in a...

In March 2026, the European market is navigating a challenging landscape marked by heightened geopolitical tensions and soaring energy prices, leading to a notable decline in key indices such as the STOXX Europe 600. As investors seek opportunities amid this volatility, identifying promising small-cap stocks that can thrive despite economic uncertainties becomes crucial.

Today is shaping up negative for Banqup Group SA ( EBR:BANQ ) shareholders, with the analysts delivering a substantial...

Syensqo (ENXTBR:SYENS) has launched its 2026 LTI Share Buyback Program, authorizing the repurchase of up to 260,000 shares to meet current and future employee Long Term Incentive Plan commitments. See our latest analysis for Syensqo. Despite today's €45.39 share price and a 1 day share price return of 4.30% suggesting a short term bounce after the buyback announcement, the 30 day share price return of 41.76% and year to date share price return of 35.08% indicate momentum has been weak. The 1...

Melexis (ENXTBR:MELE) has formally created Melexis Integrated System (Shanghai) Co., Ltd as a Wholly Foreign-Owned Enterprise in China, reshaping its local structure to support end-to-end supply chains and China-focused product development. See our latest analysis for Melexis. The new China WFOE comes at a time when Melexis shares trade at €50.6, with a 30-day share price return of a 12.08% decline and a 1-year total shareholder return of a 5.94% decline, suggesting momentum has been fading...

Warehouses Estates Belgium S.C.A (ENXTBR:WEB) has reported FY 2025 first half revenue of €15.9 million and basic EPS of €1.72, with the supplied figures indicating a net profit margin of 51.7% over the last 12 months and year on year earnings growth of 42.2%. Over recent periods, revenue has moved from €15.4 million in 1H 2024 to €13.5 million in 2H 2024 and €15.9 million in 1H 2025. Over the same span, trailing 12 month EPS has shifted from €3.13 to €3.19 and then to €4.32. For investors,...

SCR-Sibelco (ENXTBR:094426466) has put fresh numbers on the table for FY 2025, reporting first half revenue of €1.2b and net income of €78.1m, while trailing 12 month revenue is €2.3b against net income of €63.4m. Over the past year, revenue has moved from €1.1b in the first half of 2024 and €1.1b in the second half of 2024 to €1.2b in the first half of 2025. Net income shifted from €145.9m to a loss of €14.7m and then to €78.1m over the same periods. For investors, the key storyline is how...

Recent share performance and business scale Anheuser-Busch InBev (ENXTBR:ABI) has seen mixed recent share performance, with a 2% decline over the past day, a 7.2% decline over the past week, and a 12.4% decline over the past month. Over the past 3 months, the stock shows a 6.6% total return, with year to date and 1 year total returns of 8.8% and 3.2%, respectively, and a 5 year total return of 16.7%. The group operates a large global beer and beverage business, reporting revenue of €59,320.0m...

Nyxoah (ENXTBR:NYXH) just wrapped up FY 2025 with Q4 revenue of €5.6 million and a basic EPS loss of €0.586, alongside trailing twelve month revenue of €10.0 million and a basic EPS loss of €2.364 on net income losses of €90.1 million. Over recent quarters the company has seen revenue move from €1.3 million in Q4 2024 to €5.6 million in Q4 2025, while quarterly basic EPS losses widened from €0.463 to €0.586 and trailing twelve month net income losses went from €59.2 million to €90.1 million...

Brederode (ENXTBR:BREB) FY 2025 earnings snapshot Brederode (ENXTBR:BREB) has opened FY 2025 on a weak footing, with first half revenue of €177.48 million and a basic EPS loss of €4.83. Trailing 12 month revenue sits at €88.78 million with basic EPS of €4.24. Over recent periods the company has reported revenue of €184.84 million and EPS of €7.56 in 2024 H1, followed by revenue of €191.89 million and EPS of €6.54 in 2024 H2, before the current FY 2025 H1 loss. For investors, a key...

Sofina Société Anonyme (ENXTBR:SOF) has drawn investor attention after recent share price pressure, with the stock showing negative returns over the past month and past 3 months, raising questions about how its private equity profile is being valued. See our latest analysis for Sofina Société Anonyme. That recent share price pressure sits within a tougher year so far, with an 11.97% year to date share price decline and a 6.25% 1 year total shareholder return. This points to fading momentum as...

argenx (ENXTBR:ARGX) is back in focus after strong fourth quarter results and detailed analyst commentary around Vyvgart, with attention now shifting to the product’s revenue mix and upcoming clinical catalysts. See our latest analysis for argenx. Despite strong Q4 Vyvgart revenues and upcoming data presentations at the AAN meeting drawing attention to the pipeline, argenx’s recent 30 day share price return of 14.04% decline and year to date share price return of 17.13% decline contrast with...

For those wondering if Anheuser-Busch InBev at around €63.44 still offers value or if most of the upside is already priced in, this article walks through the key numbers so you can judge that for yourself. The share price has seen mixed recent returns, with about 0.2% over the last 7 days, a 6.3% decline over 30 days, 16.6% year to date, and 10.9% over the past year. This raises questions about how much of the story is already reflected in the current price. Recent headlines around...

What Elia Group’s latest earnings mean for shareholders Elia Group (ENXTBR:ELI) released full year 2025 results on 5 March, reporting sales of €4,442.2m and net income of €585.9m, figures that helped shape recent sentiment around the stock. See our latest analysis for Elia Group. Elia Group’s recent earnings update has arrived alongside firm share price momentum, with a 28.6% 90 day share price return and a 70.54% 1 year total shareholder return indicating that optimism has been building...

Recent share performance and business snapshot Umicore (ENXTBR:UMI) has drawn fresh investor attention after a period of mixed share performance, including a one month return of a 15% decline and a past three months move of about a 3% decline. The Brussels based materials and recycling group, valued at about €3.9b, reported revenue of €19,374.1m and net income of €384.5m, with annual revenue growth declining by 40.6% and net income growth of 3.4%. See our latest analysis for Umicore. At a...

D'Ieteren Group (ENXTBR:DIE) has just posted its FY 2025 numbers with first half revenue of about €4.1b and basic EPS of €4.61, backed by trailing 12 month EPS of €8.40 that lines up with reported earnings growth of 17.3% over the past year. The company has seen revenue move from about €4.3b in the first half of 2024 and €3.9b in the second half of 2024 to €4.1b in the first half of 2025. Trailing 12 month net income, excluding extra items, sits at €445m, alongside earnings growth of roughly...

DEME Group (ENXTBR:DEME) has paired its latest full year earnings release with an annual dividend announcement of €3.15 per share, giving investors fresh information on both profitability and shareholder payouts. See our latest analysis for DEME Group. At a share price of €194.4, DEME Group has seen a 36.9% 90 day share price return and a 47.45% one year total shareholder return. This suggests recent momentum has picked up as investors react to the earnings and dividend announcements. If you...

Proximus (ENXTBR:PROX) has just released its full year 2025 results, reporting €6,248 million in sales, €6,620 million in revenue, and net income of €398 million, with earnings per share of €1.23. See our latest analysis for Proximus. At a share price of €7.29, Proximus has had a mixed run, with a 9.05% decline in its 1 month share price return and a 4.29% gain over 3 months. Its 1 year total shareholder return of 16.63% contrasts with a 39.98% total shareholder return decline over five...

Cmb.Tech (ENXTBR:CMBT) has drawn investor attention after reporting full year 2025 results, declaring an interim dividend of US$0.16 per share and announcing a Management Board change involving Chief Strategy Officer Benoit Timmermans. See our latest analysis for Cmb.Tech. The share price has pulled back over the past week with a 7 day share price return of a 6.27% decline. However, the 90 day share price return of 37.34% and 1 year total shareholder return of 43.99% point to momentum that...

Syensqo SA has recently reported weaker fourth-quarter and full-year 2025 results, announced an annual dividend of €1.1340 per share for payment on 18 May 2026, redeemed €500,000,000 of 2.750% fixed-rate bonds early, and confirmed several Board changes including appointing Heike van de Kerkhof as independent Chair. These moves combine pressure on profitability with balance sheet reshaping and refreshed governance, giving investors a complex mix of cost, capital allocation and oversight...

Why UCB’s latest earnings matter for shareholders UCB (ENXTBR:UCB) has drawn fresh attention after reporting full year 2025 results, with sales of €7,388 million, revenue of €7,741 million and net income of €1,558 million, all higher than the prior year’s figures. See our latest analysis for UCB. The latest full year earnings have arrived alongside a solid run in UCB’s shares, with a 1 year total shareholder return of 52.36% and a 3 year total shareholder return above 200%. The 9.48% year to...

Shurgard Self Storage (ENXTBR:SHUR) caught investor attention after releasing its 2025 results, reporting revenue of €450.85 million and net income of €597.76 million, along with fresh 2026 guidance for 6% to 8% all store revenue growth. See our latest analysis for Shurgard Self Storage. The latest guidance and 2025 results came after a weak patch for the shares, with a 30-day share price return showing a 10.62% decline and a 1-year total shareholder return showing a 9.73% decline. The recent...

Syensqo (ENXTBR:SYENS) has announced a major reshuffle of its Board of Directors, including the appointment of Heike van de Kerkhof as independent Chair. The previous chair and long serving director is stepping down as part of the changes. A new independent director with extensive industry experience is also joining the Board. For you as an investor, Board changes like these matter because they influence how Syensqo sets priorities, manages risks and oversees management. As a specialty...

Argenx (ENXTBR:ARGX) reported positive topline Phase 3 ADAPT OCULUS results for VYVGART in adults with ocular myasthenia gravis. The study met its primary endpoint with statistically significant efficacy in this patient group, which currently has limited treatment options. The data are intended to support regulatory submissions that could extend the existing VYVGART label to include ocular myasthenia gravis. Argenx is pairing these results with a broader push to expand VYVGART indications...